Pharmacogenetics of glucocorticoid replacement could optimize the treatment of congenital adrenal hyperplasia due to 21-hydroxylase deficiency (2011)
- Authors:
- USP affiliated authors: MENDONÇA, BERENICE BILHARINHO DE - FM ; BACHEGA, TÂNIA APARECIDA SARTORI SANCHEZ - FM ; JORGE, ALEXANDER AUGUSTO DE LIMA - FM
- Unidade: FM
- DOI: 10.1590/S1807-59322011000800009
- Subjects: FARMACOGENÉTICA; HIPERPLASIA SUPRARRENAL CONGÊNITA; HIDROXILASE (DEFICIÊNCIA)
- Language: Inglês
- Imprenta:
- Source:
- Este periódico é de acesso aberto
- Este artigo NÃO é de acesso aberto
-
ABNT
MOREIRA, Ricardo P. P. et al. Pharmacogenetics of glucocorticoid replacement could optimize the treatment of congenital adrenal hyperplasia due to 21-hydroxylase deficiency. Clinics, v. 66, n. 8, p. 1361-1365, 2011Tradução . . Disponível em: https://doi.org/10.1590/S1807-59322011000800009. Acesso em: 22 jan. 2026. -
APA
Moreira, R. P. P., Jorge, A. A. L., Gomes, L. G., Kaupert, L. C., Massud Filho, J., Mendonca, B. B., & Bachega, T. A. S. S. (2011). Pharmacogenetics of glucocorticoid replacement could optimize the treatment of congenital adrenal hyperplasia due to 21-hydroxylase deficiency. Clinics, 66( 8), 1361-1365. doi:10.1590/S1807-59322011000800009 -
NLM
Moreira RPP, Jorge AAL, Gomes LG, Kaupert LC, Massud Filho J, Mendonca BB, Bachega TASS. Pharmacogenetics of glucocorticoid replacement could optimize the treatment of congenital adrenal hyperplasia due to 21-hydroxylase deficiency [Internet]. Clinics. 2011 ; 66( 8): 1361-1365.[citado 2026 jan. 22 ] Available from: https://doi.org/10.1590/S1807-59322011000800009 -
Vancouver
Moreira RPP, Jorge AAL, Gomes LG, Kaupert LC, Massud Filho J, Mendonca BB, Bachega TASS. Pharmacogenetics of glucocorticoid replacement could optimize the treatment of congenital adrenal hyperplasia due to 21-hydroxylase deficiency [Internet]. Clinics. 2011 ; 66( 8): 1361-1365.[citado 2026 jan. 22 ] Available from: https://doi.org/10.1590/S1807-59322011000800009 - Frequency of genetic polymorphisms of PXR gene in the Brazilian population
- The effect of fetal androgen metabolism-related gene variants on external genitalia virilization in congenital adrenal hyperplasia
- Growth hormone deficiency with advanced bone age: phenotypic interaction between GHRH receptor and CYP21A2 mutations diagnosed by sanger and whole exome sequencing
- Long-Term dexamethasone treatment is not associated with obesity and or metabolic syndrome in adult patients with classical forms of 21-hydroxylase deficiency
- Increased expression of ACTH (MC2R) and androgen (AR) receptors in giant bilateral myelolipomas from patients with congenital adrenal hyperplasia
- Influence of the a3669g Glucocorticoid receptor gene polymorphism on the metabolic profile of pediatric patients with congenital adrenal hyperplasia
- Fadiga e doenças endócrinas
- Neonatal 17-hydroxyprogesterone levels adjusted according to age at sample collection and birthweight improve the efficacy of congenital adrenal hyperplasia newborn screening
- Classic congenital adrenal hyperplasia and its impact on reproduction
- Mineralocorticoid replacement during infancy for salt wasting congenital adrenal hyperplasia due to 21-hydroxylase deficiency
Informações sobre o DOI: 10.1590/S1807-59322011000800009 (Fonte: oaDOI API)
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
